Indexed in Journament

journal of hepatocellular carcinoma

EN

Journal Website Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
33.6 / 100
Journament Score
Poor
Ranked #18,091 of 29,341 scored journals (33,995 indexed)
194 Articles
Scores higher than 38.3% of scored journals
050100
The Journament Score is computed from platform statistics — reader engagement, accessibility, publication timeliness, keyword breadth, community impact and content distribution — into a single 0–100 figure, recalculated as new articles and metadata are indexed. Dimensions that cannot be measured for this journal are excluded rather than estimated. It is independent of the paid AI Quality Analysis, which never affects this score or the ranking. Full methodology →

About This Journal

Short Name journal of hepatocellular carcinoma
Abbreviated Name journal of hepatocellular carcinoma
URL https://www.dovepress.com/journal-of-hepatocellular-carcinoma-journal

Quality Profile

7 of 12 dimensions measured
This journal Average of scored journals
Platform statistics — the free Journament Score AI Quality Analysis — separate paid product, ranks nothing

5 of the 12 dimensions could not be measured for this journal. They are left as gaps in the shape rather than plotted as zero.

Show the numbers
Dimension This journal Corpus average
Engagement 30.5 30.1
Accessibility 35.0 17.9
Timeliness 0.0 19.2
Diversity 63.4 28.8
Innovation 7.5 31.2
Community Impact 4.3 13.4
Content Distribution 79.4 88.4
Content Quality — 55.5
Ethics & Transparency — 40.2
Editorial Standards — 33.4
Publication Regularity — 53.2
Geographic Reach — 30.8

Publications Per Year

Articles (194)

2017
Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions
Emily M Ray;Hanna K Sanoff and
Vol. 4 , pp. 131-138
459 views DOI Abstract
2015
Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial
Hosny Salama;Hassan Ahmad;Ismail Elchagea;Abdel Rahman Zekri;Eman Medhat;Abeer Bahnassy;Michael Lange;Mohammed Rabbat;Andrew N de la Torre;Pravin Punamiya and
Vol. 2 , pp. 79-89
438 views DOI Abstract
2018
Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance
Anna S Griffith;Paul H Hayashi;Lauren MB Burke;Autumn J McRee;
Vol. 5 , pp. 55--59
417 views DOI Abstract
2017
A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect
Andrew N de la Torre;Sohail Contractor;Ismael Castaneda;Charles S Cathcart;Dolly Razdan;David Klyde;Piotr Kisza;Sharon F Gonzales;Andres M Salazar;
Vol. 4 , pp. 111--121
416 views DOI Abstract
2018
Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance
Anna S Griffith;Paul H Hayashi;Lauren MB Burke;Autumn J McRee and
Vol. 5 , pp. 55-59
412 views DOI Abstract
2018
Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt
Mohamed Kamal Shaker;Iman F Montasser;Mohamed Sakr;Mohamed Elgharib;Hany M Dabbous;Hend Ebada;Ahmed El Dorry;Mohamed Bahaa;Mahmoud El Meteini and
Vol. 5 , pp. 29-36
407 views DOI Abstract
2016
Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary
Gerald J Mizejewski and
Vol. 3 , pp. 37-40
401 views DOI Abstract
2017
A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect
Andrew N de la Torre;Sohail Contractor;Ismael Castaneda;Charles S Cathcart;Dolly Razdan;David Klyde;Piotr Kisza;Sharon F Gonzales;Andres M Salazar and
Vol. 4 , pp. 111-121
399 views DOI Abstract
2018
Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria
Victor Amado;Manuel Rodríguez-Perálvarez;Gustavo Ferrín;Manuel De la Mata and
Vol. 6 , pp. 1-10
398 views DOI Abstract
2018
Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria
Victor Amado;Manuel Rodríguez-Perálvarez;Gustavo Ferrín;Manuel De la Mata;
Vol. 6 , pp. 1--10
389 views DOI Abstract
2019
Weighing the benefits of hepatocellular carcinoma surveillance against potential harms
Daniel Geh;Fahd A Rana;Helen L Reeves;
Vol. 6 , pp. 23--30
272 views DOI Abstract
2019
Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
Nicola Personeni;Tiziana Pressiani;Lorenza Rimassa;
Vol. 6 , pp. 31--39
162 views DOI Abstract
2019
Road map for fibrolamellar carcinoma: progress and goals of a diversified approach
Edward R Kastenhuber;John Craig;Jon Ramsey;Kevin M Sullivan;Julien Sage;Sofia de Oliveira;Kimberly J Riehle;John D Scott;John D Gordan;Nabeel Bardeesy;Ghassan K Abou-Alfa;
Vol. 6 , pp. 41--48
218 views DOI Abstract
2019
LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance
Khaled M Elsayes;Ania Z Kielar;Victoria Chernyak;Ali Morshid;Alessandro Furlan;William R Masch;Robert M Marks;Aya Kamaya;Richard KG Do;Yuko Kono;Kathryn J Fowler;An Tang;Mustafa R Bashir;Elizabeth M Hecht;Kedar Jambhekar;Andrej Lyshchik;Shuchi K Rodgers;Jay P Heiken;Marc Kohli;David T Fetzer;Stephanie R Wilson;Zahra Kassam;Mishal Mendiratta-Lala;Amit G Singal;Christopher S Lim;Irene Cruite;James Lee;Ryan Ash;Donald G Mitchell;Matthew DF McInnes;Claude B Sirlin;
Vol. 6 , pp. 49--69
348 views DOI Abstract
2019
Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives
Li-Chun Lu;Chun-Jung Chang;Chih-Hung Hsu;
Vol. 6 , pp. 71--84
262 views DOI Abstract
2019
Post-translational modifiers of liver kinase B1/serine/threonine kinase 11 in hepatocellular carcinoma
Teresa Cardoso Delgado;Fernando Lopitz-Otsoa;María Luz Martínez-Chantar;
Vol. 6 , pp. 85--91
221 views DOI Abstract
2019
Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve
Nicholas Fidelman;Curt Johanson;Maureen P Kohi;K Pallav Kolli;Ryan M Kohlbrenner;Evan D Lehrman;Andrew G Taylor;R Kate Kelley;Francis Y Yao;John P Roberts;Robert K Kerlan;
Vol. 6 , pp. 93--103
284 views DOI Abstract
2019
Intermediate stage hepatocellular carcinoma: a summary review
Omar Elshaarawy;Asmaa Gomaa;Hazem Omar;Eman Rewisha;Imam Waked;
Vol. 6 , pp. 105--117
188 views DOI Abstract
2019
Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma
Katerina Zakka;Renjian Jiang;Olatunji B Alese;Walid L Shaib;Christina Wu;Joel P Wedd;Marty T Sellers;Madhusmita Behera;Bassel F El-Rayes;Mehmet Akce;
Vol. 6 , pp. 119--129
194 views DOI Abstract
2019
Status of, and strategies for improving, adherence to HCC screening and surveillance
Giampiero Francica;Mauro Borzio;
Vol. 6 , pp. 131--141
234 views DOI Abstract
Journament Score
33.6/100 · Poor
Ranked #18,091 of 29,341 scored
(33,995 journals indexed)
Platform Statistics
AI Quality Analysis
Separate paid analysis — does not affect ranking.
Journament

Overall Quality Score

33.6/100

Tier: Poor

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

30.5/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

35.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

63.4/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

7.5/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

4.3/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

0.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Content Distribution

79.4/100

Measures how evenly reader attention spreads across the journal's articles, using the Gini coefficient of article clicks.

Higher scores mean readership is distributed across many articles rather than concentrated on one or two.

Ethics & Transparency Score

Not yet measured

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

Not yet measured

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

Not yet measured

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

Not yet measured

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

Not yet measured

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.